Average Co-Inventor Count = 2.32
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. University of Pittsburgh (15 from 1,860 patents)
2. Other (1 from 832,680 patents)
3. Medimmune Limited (1 from 541 patents)
4. Intrexon Corporation (1 from 121 patents)
16 patents:
1. 11787846 - EphA2 T-cell epitope agonists and uses therefore
2. 11723963 - Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response
3. 10781240 - EPHA2 t-cell epitope agonists and uses therefore
4. 10434155 - Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response
5. 10131699 - EphA2 T-cell epitope agonists and uses therefore
6. 9937250 - Immunogenic tumor associated stromal cell antigen peptides and methods of their use
7. 9675642 - Engineered dendritic cells and uses for the treatment of cancer
8. 9359402 - EphA2 T-cell epitope agonists and uses therefore
9. 9345770 - Immunogenic tumor associated stromal cell antigen peptides and methods of their use
10. 8859488 - Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response
11. 8574584 - EphA2 T cell epitopes and uses therefor
12. 8114407 - EphA2 T-cell epitopes and uses therefor
13. 7612162 - Peptide analogs capable of enhancing stimulation of a glioma-specific CTL response
14. 7297337 - EphA2 T-cell epitopes and uses therefor
15. 6077519 - Methods for isolation and use of T cell epitopes eluted from viable